{
  "id": "80fedfc523aa41c9",
  "title": "Ocular Therapeutix , Inc . Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI in Wet AMD",
  "description": "20251209T081500Z",
  "content": "",
  "source": "marketscreener.com",
  "source_url": "https://www.marketscreener.com/news/ocular-therapeutix-inc-announces-plans-to-accelerate-nda-submission-timeline-for-axpaxli-in-wet-am-ce7d51d2dc88f322",
  "published_at": "20251209T081500Z",
  "fetched_at": "2025-12-10T00:22:54.894572+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "",
  "raw_data": {
    "url": "https://www.marketscreener.com/news/ocular-therapeutix-inc-announces-plans-to-accelerate-nda-submission-timeline-for-axpaxli-in-wet-am-ce7d51d2dc88f322",
    "url_mobile": "",
    "title": "Ocular Therapeutix , Inc . Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI in Wet AMD",
    "seendate": "20251209T081500Z",
    "socialimage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
    "domain": "marketscreener.com",
    "language": "English",
    "sourcecountry": ""
  }
}